Correspondence

Further advice on U-47,700, etizolam and other designer benzodiazepines

Further letter from the Advisory Council on the Misuse of Drugs about U-47,700 and designer benzodiazepines.

• From: Advisory Council on the Misuse of Drugs and Home Office
• Published: 22 December 2016
• Last updated: 10 March 2017 — See all updates

Documents

Response from Sarah Newton: further advice on U-47,700 and designer benzodiazepines

PDF, 70.7 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Further ACMD advice on U-47,700, etizolam and other designer benzodiazepines

PDF, 163 KB, 3 pages

Addendum to advice on U-47,700, etizolam and other designer benzodiazepines

PDF, 133 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The chair of the ACMD, Les Iversen, replies to Minister for Vulnerability, Safeguarding and Countering Extremism Sarah Newton about:

• the opioid U-47,700
• designer benzodiazepines

Read the ACMD’s original advice and Sarah Newton’s response.

Published 22 December 2016
Last updated 10 March 2017 + show all updates

1. 10 March 2017

   Published addendum on U-47,700, etizolam and other designer benzodiazepines.

2. 8 February 2017

   Added the latest response from Sarah Newton

3. 22 December 2016

   First published.